First Participant Dosed in IMG-004 Trial for Immunological Diseases
source: pixabay.com

First Participant Dosed in IMG-004 Trial for Immunological Diseases

  Near the start of August 2022, biotechnology company Inmagene Biopharmaceuticals ("Inmagene") and biopharmaceutical company HUTCHMED shared via news release that the first participant had been dosed in a Phase…

Continue Reading First Participant Dosed in IMG-004 Trial for Immunological Diseases
Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
source: pixabay.com

Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!

Severe Combined Immunodeficiency Severe combined immunodeficiency (SCID) is a group of diseases caused by mutations that affect how the immune system works to fight infections. These anomalies are usually passed…

Continue Reading Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech
source: pixabay.com

X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech

According to a story from BioSpace, SIRION Biotech GmbH and Mustang Bio, Inc. have announced a new agreement for licensing the use of SIRION's proprietary LentiBOOST™ technology for use by…

Continue Reading X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech
Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus
source: pixabay.com

Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus

  Michael and Armené Kapamajian were at home in Los Angeles settling in with their one week old baby, Sasoun, when their doctor called and asked them to come in…

Continue Reading Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus
ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
source: pixabay.com

ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment

According to a story from gurufocus.com, the biopharmaceutical company ADMA Biologics, Inc., has earned the 2020 BioNJ Innovator Award. This award was given as acknowledgement of the company's successful development…

Continue Reading ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
stanvpetersen / Pixabay

Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

According to a story from the Warwick Beacon, the first ever primary immunodeficiency (PI) awareness and fundraising walk in Rhode Island's history was held recently at Warwick City Park. The…

Continue Reading Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

SCID Severe combined immunodeficiency (SCID) is a rare disease which causes patients to have little to no immune response. With practically no immune system, SCID patients are very susceptible to…

Continue Reading Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

Analysis of Phase 3 Study Shows Inolimomab has Long-term Clinical Benefit for Graft-Versus-Host-Disease

About Graft-Versus-Host-Disease (GvHD) Graft-Versus-Host-Disease (GvHD) occurs when a patient's body rejects cells which have been transplanted. For instance, it may develop following a stem cell transplant or a bone marrow transplant. The…

Continue Reading Analysis of Phase 3 Study Shows Inolimomab has Long-term Clinical Benefit for Graft-Versus-Host-Disease